Work

Association of high circulating neuregulin-1 with clinical benefit in EGFR wild-type NSCLC patients treated with rilotumumab and erlotinib.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e20647

Authors: Laura P. Stabile, Ahmad A. Tarhini, Mariya Farooqui, Jose Gomez-Garcia, Autumn Gaither-Davis, William E. Gooding, Mark A. Socinski, Jill M. Siegfried

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Minnesota

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891292960

Cites:

Cited by:

Related to: 10